CytoMed Therapeutics Limited Cash And Cash Equivalents
CytoMed Therapeutics Limited (GDTC) had Cash And Cash Equivalents of SGD 2.10 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-31
- 2025-12-31: Cash And Cash Equivalents 2.10M SGD.
- 2024-12-31: Cash And Cash Equivalents 4.70M SGD.
- 2023-12-31: Cash And Cash Equivalents 6.22M SGD.
- 2022-12-31: Cash And Cash Equivalents 1.58M SGD.
SGD
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | 2.10M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 4.70M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 6.22M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 1.58M SGD 20-F · filed 2026-03-31 |
| 2021-12-31 | 2.51M SGD 20-F · filed 2025-04-28 |
| 2020-12-31 | 885.27K SGD 20-F · filed 2024-04-22 |
| 2019-12-31 | 370.94K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $1.63M 20-F · filed 2026-03-31 | |
| 2024-12-31 | $3.65M 20-F · filed 2026-03-31 | $3.44M 20-F · filed 2025-04-28 |
| 2023-12-31 | $4.56M 20-F · filed 2025-04-28 | $4.72M 20-F · filed 2024-04-22 |
| 2022-12-31 | $1.20M 20-F · filed 2024-04-22 | $1.18M 20-F · filed 2023-05-01 |
| 2021-12-31 | $1.87M 20-F · filed 2023-05-01 |